Matches in SemOpenAlex for { <https://semopenalex.org/work/W4284973205> ?p ?o ?g. }
- W4284973205 endingPage "22" @default.
- W4284973205 startingPage "9" @default.
- W4284973205 abstract "IMPORTANCE: The evidence that maintaining a healthy body weight in conjunction with healthier eating patterns, exercise training, and reduced stress can improve clinical outcomes in patients with atherosclerotic cardiovascular disease is substantial. However, little is known about the magnitude and temporal effects of a comprehensive lifestyle treatment on coronary artery anatomy, myocardial inflammation, and fibrosis in people affected by coronary heart disease. OBJECTIVE: To conduct a randomised clinical trial to determine the impact of a 12-month intense lifestyle intervention delivered via an mHealth platform (in the form of a mobile App) versus standard clinical care on low attenuation plaque volume and structure, stress myocardial perfusion, and diastolic function. DESIGN: A single centre, parallel-group, randomised controlled trial. The co-primary endpoints are: 1-Low Attenuation Plaque (LAP) volume (mm3) using coronary computed tomography angiography (CCTA) at 12 months, and 2-Adenosine stress myocardial blood flow (stress MBF, mL/min/g) using cardiovascular magnetic resonance imaging (MRI) at 12 months. Other key measurements include liver steatosis by MRI, subclinical abnormalities detected by advanced electrocardiography, arterial stiffness, endothelial function, genomic, metabolomic, and gut microbiome-related adaptations to these structural changes. An intention-to-treat principle will be used for all analyses. SETTING: Participants will be recruited from a large academic cardiology office practice (Central Sydney Cardiology) and Royal Prince Alfred Hospital (RPAH) Departments of Cardiology and Radiology. All clinical investigations will be undertaken within the Charles Perkins Centre-RPAH clinic. PARTICIPANTS: Individuals (n = 150) with stable coronary heart disease who have low attenuation plaque based on a CCTA within the past 3 months, will be randomised to a lifestyle intervention program comprising a 5:2 pesco-vegetarian diet, exercise training, and mindfulness-based stress reduction (n = 75) or usual care (n = 75). DISCUSSION: This trial will represent the single most detailed and integrated analysis of the effects of a comprehensive lifestyle intervention targeting multiple metabolic pathways, delivered via a customized mHealth App on smart devices, on coronary macro- and microcirculation, heart physiology, and cardiometabolic risk. It will provide a new framework for allowing clinicians and individuals to optimise metabolic health for the prevention and management of atherosclerotic cardiovascular diseases that is epidemic in modern society." @default.
- W4284973205 created "2022-07-10" @default.
- W4284973205 creator A5003045336 @default.
- W4284973205 creator A5003360183 @default.
- W4284973205 creator A5005867158 @default.
- W4284973205 creator A5007885250 @default.
- W4284973205 creator A5013126111 @default.
- W4284973205 creator A5013462750 @default.
- W4284973205 creator A5025203839 @default.
- W4284973205 creator A5028868772 @default.
- W4284973205 creator A5030681454 @default.
- W4284973205 creator A5033976907 @default.
- W4284973205 creator A5034315013 @default.
- W4284973205 creator A5039193038 @default.
- W4284973205 creator A5040369505 @default.
- W4284973205 creator A5040969461 @default.
- W4284973205 creator A5045545412 @default.
- W4284973205 creator A5061383804 @default.
- W4284973205 creator A5061423043 @default.
- W4284973205 creator A5067324486 @default.
- W4284973205 creator A5068274975 @default.
- W4284973205 creator A5069436670 @default.
- W4284973205 creator A5069724066 @default.
- W4284973205 creator A5076235819 @default.
- W4284973205 creator A5077231143 @default.
- W4284973205 creator A5029858585 @default.
- W4284973205 date "2022-10-06" @default.
- W4284973205 modified "2023-10-16" @default.
- W4284973205 title "Impact of an intensive lifestyle program on low attenuation plaque and myocardial perfusion in coronary heart disease: A randomised clinical trial protocol" @default.
- W4284973205 cites W1982939489 @default.
- W4284973205 cites W1991334358 @default.
- W4284973205 cites W2009187570 @default.
- W4284973205 cites W2020583682 @default.
- W4284973205 cites W2030180893 @default.
- W4284973205 cites W2050134733 @default.
- W4284973205 cites W2089506664 @default.
- W4284973205 cites W2093983853 @default.
- W4284973205 cites W2094981066 @default.
- W4284973205 cites W2095152560 @default.
- W4284973205 cites W2114031002 @default.
- W4284973205 cites W2119679507 @default.
- W4284973205 cites W2131110587 @default.
- W4284973205 cites W2134775482 @default.
- W4284973205 cites W2161900439 @default.
- W4284973205 cites W2166000498 @default.
- W4284973205 cites W2166543052 @default.
- W4284973205 cites W2169090109 @default.
- W4284973205 cites W2169434152 @default.
- W4284973205 cites W2460846739 @default.
- W4284973205 cites W2474213459 @default.
- W4284973205 cites W2508214571 @default.
- W4284973205 cites W2598772200 @default.
- W4284973205 cites W2615003157 @default.
- W4284973205 cites W2729775538 @default.
- W4284973205 cites W2758845902 @default.
- W4284973205 cites W2763651817 @default.
- W4284973205 cites W2765231112 @default.
- W4284973205 cites W2766727533 @default.
- W4284973205 cites W2773791657 @default.
- W4284973205 cites W2774826291 @default.
- W4284973205 cites W2791783341 @default.
- W4284973205 cites W2803282494 @default.
- W4284973205 cites W2807970930 @default.
- W4284973205 cites W2811320128 @default.
- W4284973205 cites W2909712060 @default.
- W4284973205 cites W2913539192 @default.
- W4284973205 cites W2916366468 @default.
- W4284973205 cites W2958102462 @default.
- W4284973205 cites W2958408897 @default.
- W4284973205 cites W2979402731 @default.
- W4284973205 cites W2982228070 @default.
- W4284973205 cites W3011406860 @default.
- W4284973205 cites W3056347457 @default.
- W4284973205 cites W3082900190 @default.
- W4284973205 cites W3083406534 @default.
- W4284973205 cites W3106940915 @default.
- W4284973205 cites W3113178943 @default.
- W4284973205 cites W3155824129 @default.
- W4284973205 doi "https://doi.org/10.3233/nha-210146" @default.
- W4284973205 hasPublicationYear "2022" @default.
- W4284973205 type Work @default.
- W4284973205 citedByCount "3" @default.
- W4284973205 countsByYear W42849732052023 @default.
- W4284973205 crossrefType "journal-article" @default.
- W4284973205 hasAuthorship W4284973205A5003045336 @default.
- W4284973205 hasAuthorship W4284973205A5003360183 @default.
- W4284973205 hasAuthorship W4284973205A5005867158 @default.
- W4284973205 hasAuthorship W4284973205A5007885250 @default.
- W4284973205 hasAuthorship W4284973205A5013126111 @default.
- W4284973205 hasAuthorship W4284973205A5013462750 @default.
- W4284973205 hasAuthorship W4284973205A5025203839 @default.
- W4284973205 hasAuthorship W4284973205A5028868772 @default.
- W4284973205 hasAuthorship W4284973205A5029858585 @default.
- W4284973205 hasAuthorship W4284973205A5030681454 @default.
- W4284973205 hasAuthorship W4284973205A5033976907 @default.
- W4284973205 hasAuthorship W4284973205A5034315013 @default.
- W4284973205 hasAuthorship W4284973205A5039193038 @default.
- W4284973205 hasAuthorship W4284973205A5040369505 @default.